The left-heads are fantasticly shitty
about business next
The left-heads are fantasticly shitty
about business next getting to create things
and bringing cash and assets home and
bottom wage earners getting double tax deductions.
These dems have mud between their ears.
Actually it is worse than that.
We are use to seeing them as just stupid.
Not,
The case: they are sick/whacked and full of intent to infect and destroy.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Harvard's Digital Shift: Accessible Education for Teens Harvard University is throwing the academic doors wide open, welcoming high school students from every corner of the globe through its new online portal, Harvard Digital Discovery. Picture this—a young mind in a small town anywhere can now tap into Harvard's intellectual vault without booking a flight or summer...
Continue Reading
Databento Defies Industry Norms Right out of the gate, this Databento story is a head-turner. They just rolled out the big guns with $100 million in fresh Series C financing, and it catapults them to a $1.1 billion valuation. Now, if that doesn't make you sit up and take notice, what will? They've done this while keeping headcount lean, just 39 stalwart employees—talk...
Continue Reading
Fresh Face at the Helm Hiring Mark McSpadden as Chief Product Officer is a move by FCM Travel that signals the company's intent to deepen its roots in tech and innovation within the corporate travel sector. There's no subtlety here—FCM's making a bold statement, and they're throwing serious weight behind their tech strategy. Don’t take this lightly; this is them...
Continue Reading
Omni Helicopters Charts New Financial Horizons When Omni Helicopters International (OHI) rawly gathers R$200 million under its financial belt, it’s clear someone’s eyeing horizons beyond the immediate. This hefty chunk, clocking in at roughly $38 million, emerges from a duo of noteworthy financing facilities and marks a strategic maneuver as OHI aligns itself for cash...
Continue Reading
Breaking Away From the Subscription Cycle When's the last time you saw a price that didn't make you groan? Halfpricesoft.com seems to have stumbled upon the magic number with their $169 flat-rate deal. You might think this feels like one of those golden eggs in a nest of subscription fatigue—and you'd be right. As inflation ramps up costs, especially for small...
Continue Reading
Allstate Keeps the Dividend Train Rolling in 2027 Today, Allstate Corporation is back in the headlines, and no, it's not about any flashy new product or some flashy CEO speech. It's about cold, hard cash making its way into investors' pockets. The board just gave the nod to a quarterly dividend of $1.08 per share, slated to hit the books on January 4, 2027. If you're...
Continue Reading
Unpacking GFL Environmental's Share Conversion Here's a doozy straight from the gritty world of finance: GFL Environmental Inc. (NYSE: GFL) has announced a hefty conversion of Series A Preferred Shares into a whopping 6,219,896 subordinate voting shares. That's right, those Series A Preferred Shares, helmed by HPS Investment Partners, LLC, are now converted and sold in a...
Continue Reading
Revolutionizing Seafood Logistics with Kargo You'd think managing seafood shipments would be a simpler gig than charting ocean routes, but think again. Northern Wind, a major player in seafood processing, just proved the power of tech in an old-school business by partnering with a slick AI outfit called Kargo. Their facility in New Bedford, Massachusetts now magically...
Continue Reading
Breaking Free from Animal-Derived Components It feels like every biotech firm out there wants to ditch animal components these days, and TheWell Bioscience is no exception. With their new RocketCell™ S1, S2, and S3 supplements, they're diving headlong into the trend of animal origin-free (AOF) cell culture solutions. It's a smart move for researchers frustrated by the...
Continue Reading
Water Utility Backs First Responders with Bigger Bucks Listen up, folks. The New Jersey American Water company just threw down the gauntlet with some bold moves for its 2027 Volunteer Fire and EMS Grant Program. They've taken the maximum grant amount from $2,500 to $5,000. Yeah, you heard right. Doubling the pot and starting the application cycle earlier means volunteer...
Continue Reading
Top 5 Most Recently Viewed Articles
Actinium Pharmaceuticals: A Closer Look at the Lawsuit Recently, a significant class action lawsuit was filed against Actinium Pharmaceuticals, Inc. (NYSE: ATNM). This legal action is vital for investors who have experienced financial losses associated with their investments in Actinium's stock. The lawsuit, initiated by Pomerantz LLP, accuses the company and some of its...
Continue Reading
Uranium Energy Corp Unveils Outstanding Drilling Results Uranium Energy Corp (NYSE American: UEC) is thrilled to share the latest findings from its active drilling campaign at the Roughrider Project, which have revealed striking high-grade uranium mineralization. A drill hole positioned 850 meters northeast of the central Roughrider deposit has showcased remarkable...
Continue Reading
TME Pharma's Progress in Glioblastoma Treatment TME Pharma N.V. is a clinical-stage biotechnology company dedicated to developing innovative therapies for cancer. Recently, they announced an important oral presentation at a renowned medical congress, showcasing the encouraging results from the NOX-A12 GLORIA Phase 1/2 trial. This study aims to address glioblastoma, a...
Continue Reading
Life Time Champions Expanding Pickleball Facilities Across U.S. Life Time (NYSE: LTH) proudly marks World Pickleball Day as the sport continues to gain unprecedented popularity across America. With over 750 permanent pickleball courts established within its athletic country clubs, the organization demonstrates its commitment to being at the forefront of this dynamic...
Continue Reading
Edgewise Therapeutics Announces Significant Progress in Hypertrophic Cardiomyopathy Treatment Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a pioneering biopharmaceutical company focused on muscle diseases, has recently disclosed positive outcomes from their Phase 2 CIRRUS-HCM trial studying EDG-7500. This treatment targets hypertrophic cardiomyopathy (HCM), a serious...
Continue Reading